Toy et al. 2016 |
- |
Prospective, Randomize, Fellow eye-controlled clinical trial |
71 patients |
12 months follow up |
WFO-PRK using the WaveLight Allegretto Eye-Q 400-Hz (Alcon) |
WFG-PRK using the VISX CustomVue Star S4 IR |
Sia et al. 2015 |
- |
Prospective randomized open-label study |
108 patients |
(1,3,6,12) months follow up |
Wavefront-guided |
Wavefront-optimized treatment |
Ryan et al. 2017 |
1097525 |
prospective, randomized clinical trial |
56 patients |
(6,12) months follow up |
Wavefront-guided (WFG) |
Wavefront-optimized (WFO) photorefractive keratectomy (PRK) |
Moshirfar et al. 2011 |
- |
Prospective, single-masked, randomized, fellow-eye study |
23 patients |
Three months follow up |
WaveLight Allegretto system (Wavefront-optimized group), which utilizes the WaveLight® Allegretto 400 Hz Wave® Eye-Q Laser |
VISX CustomVueTM STAR S4 IRTM Excimer Laser with Active Track |
Maurer et al. 2014 |
- |
prospective randomized study |
27 patients |
(1,3,6) months follow up |
WFG PRK, WFG LASIK |
WFO PRK and WFG LASIK |
Lee et al. 2016 |
1135719 |
prospective randomized study |
68 patients |
12 months follow up |
Wavefront-guided PRK (VISX CustomVue Star S4 IR excimer laser system |
Wavefront-optimized PRK (WaveLight Allegretto Wave EyeQ 400 Hz excimer laser system; Alcon Laboratories, Inc., Fort Worth, TX) |
He et al. 2015 |
1135719 |
Prospective, randomized, fellow-eye controlled clinical trial |
71 patients |
(1,3,6,12) months follow up |
WFG PRK (Visx CustomVue Star S4IR excimer laser system; Abbott Medical Optics) |
WFO PRK (WaveLight Allegretto Wave Eye-Q 400 Hz excimer laser system; Alcon Surgical) |
He et al. 2014 |
1135719 |
Prospective, randomized, fellow eye controlled study |
71 patients |
(1,3,6,12) months follow up |
WFG PRK treatment by the VISX CustomVue Star S4 IR excimer laser system |
WFO PRK treatment by the WaveLight Allegretto Wave Eye-Q 400 Hz excimer laser system |